Blog
May 15, 2023
Poster sessions at AACR: a recap
We were grateful for the opportunity to attend and present at the AACR Annual Meeting last week, where three of our scientists highlighted some of the exciting work happening in our Vancouver lab.
We’re thrilled to announce that Imagia Canexia Health is a finalist for the Reuters Events Pharma Awards, in the Driving Health Equity category. By enabling health systems to provide cost-effective testing in-house, we’re closing the health equity gap in oncology by delivering precision cancer treatments to patients no matter where they live.
The winner of this award, to be announced December 1st, will be an initiative which has demonstrably worked to deliver on driving equitable access for patients in underserved communities – such includes but is not limited to educational programs, outreach and awareness campaigns, advocacy partnership or research studies that helped to dismantle societal barriers to equitable medicine use.
Congratulations to our fellow finalists Merck, Organon, Takeda, CSL Behring!
Details: https://bit.ly/3LBtLDQ
Recent Resources
Press
March 28, 2023
Imagia Canexia Health Announces Three Abstracts to be Presented at AACR Annual Meeting 2023 Highlighting the Company’s Latest Research Findings
Imagia Canexia Health announced that three abstracts highlighting the company’s new learnings and tools will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19, 2023, at the Orange County Convention Center in Orlando, Florida.
Webinar
March 27, 2023
Project ACTT Webinar
Project ACTT (Access to Cancer Testing and Treatment) in Response to COVID-19 was a joint effort led by Imagia Canexia Health and supported by Digital Supercluster and partner institutions.